ATRA · Atara Biotherapeutics, Inc.
$8.09
-0.42 (-4.94%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we have concluded that substantial doubt exists with respect to our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$81.21M
Shares
10.04M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ATRA
22 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 158,646 | $750,396 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 29,408 | $309,078 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 56,372 | $266,640 | 0.00% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 10,479 | $110,134 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 8,665 | $91,069 | 0.00% | Long | 2026-05-31 | |
| Ultra-Small Company Fund | — | 18,691 | $88,408 | 0.10% | Long | 2026-03-31 | |
| VIP Disciplined Small Cap Portfolio | — | 16,238 | $76,806 | 0.01% | Long | 2026-03-31 | |
| Ultra-Small Company Market Fund | — | 14,000 | $66,220 | 0.05% | Long | 2026-03-31 | |
| Goldman Sachs Human Evolution ETF | GBIL | 4,721 | $63,639 | 0.13% | Long | 2020-08-31 | |
| iShares Micro-Cap ETF | — | 10,445 | $49,405 | 0.00% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 4,612 | $48,472 | 0.00% | Long | 2026-05-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | ABUF | 1,940 | $34,726 | 0.48% | Long | 2021-09-30 | |
| ProShares UltraPro Nasdaq Biotechnology | ANEW | 1,256 | $15,260 | 0.08% | Long | 2020-02-29 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 2,844 | $13,452 | 0.00% | Long | 2026-03-31 | |
| Dimensional US Core Equity 1 ETF | — | 2,149 | $10,251 | 0.00% | Long | 2026-04-30 | |
| Schwab Total Stock Market Index Fund | — | 1,643 | $7,837 | 0.00% | Long | 2026-04-30 | |
| iShares Evolved U.S. Innovative Healthcare ETF | AGRH | 2,136 | $6,472 | 0.02% | Long | 2022-07-31 | |
| Dimensional U.S. Core Equity 2 ETF | — | 880 | $4,198 | 0.00% | Long | 2026-04-30 | |
| Principal Healthcare Innovators ETF | BCHP | 446 | $3,791 | 0.02% | Long | 2024-06-30 | |
| 1290 VT Micro Cap Portfolio | — | 776 | $3,670 | 0.00% | Long | 2026-03-31 | |
| Dimensional U.S. Small Cap ETF | — | 135 | $644 | 0.00% | Long | 2026-04-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 564 | $2,668 | 0.00% | Short | 2026-03-31 |
Showing 1–22 of 22 positions
Key facts
CIK
1604464
CUSIP
046513206
13F (30d)
38 filings
36 filers
Visit website
Investor relations